| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 01/15/2004 | WO2003094950A8 A method of inhibiting the emigration of cells from the intravascular compartment into tissues |
| 01/15/2004 | WO2003092608A3 Methionine aminopeptidase-2 inhibitors and methods of use thereof |
| 01/15/2004 | WO2003089572A3 Essential and important genes of pseudomonas aeroginosa and the use thereof to design or identify antibacterial agents |
| 01/15/2004 | WO2003088920A8 Low profile combination device for gastrostomy or jejunostomy applications having anti-granuloma formation characteristics |
| 01/15/2004 | WO2003086272A3 Ultrapure transferrin for pharmaceutical compositions |
| 01/15/2004 | WO2003082216A3 Neuroprotectant methods, compositions, and screening methods thereof |
| 01/15/2004 | WO2003080794A3 Inhibition of rna function by delivery of inhibitors to animal cells |
| 01/15/2004 | WO2003079969A3 Compositions and methods for treating and preventing necrosis |
| 01/15/2004 | WO2003078456A3 Human diabetes-mediating proteins |
| 01/15/2004 | WO2003074667A3 Ku-70-derived bax-suppressing peptides and use thereof for the protection of damaged cells |
| 01/15/2004 | WO2003072126A3 Use of a fibroblast growth factor-binding protein for the treatment and diagnosis of diabetic wound healing problems |
| 01/15/2004 | WO2003070905A3 Electroporation methods for introducing bioactive agents into cells |
| 01/15/2004 | WO2003070895A3 RNA INTERFERENCE MEDIATED TREATMENT OF ALZHEIMER'S DISEASE USING SHORT INTERFERING NUCLEIC ACID (siNA) |
| 01/15/2004 | WO2003070195A3 Biglycan and related therapeutics and methods of use |
| 01/15/2004 | WO2003068936A3 Inhibition of lung metastases by aerosol delivery of p53 gene and anti-cancer compounds |
| 01/15/2004 | WO2003063904A3 Tissue adhesion formation control |
| 01/15/2004 | WO2003063786A3 Methods and composition for delivering nucleic acids and/or proteins to the respiratory system |
| 01/15/2004 | WO2003061684A3 Tumour treatment compositions comprising hsp70 and tumour necrosis factor |
| 01/15/2004 | WO2003061587A3 USE OF TGF-β ANTAGONISTS TO TREAT OR TO PREVENT CHRONIC TRANSPLANT REJECTION |
| 01/15/2004 | WO2003060130A3 Pim-3 kinase as a target for type 2 diabetes mellitus |
| 01/15/2004 | WO2003060072A3 Recombinant polypeptides |
| 01/15/2004 | WO2003059933A3 Conformationally constrained c-backbone cyclic peptides |
| 01/15/2004 | WO2003057847A8 METHODS AND MATERIALS FOR MODULATING ENaC-BETA |
| 01/15/2004 | WO2003057170A8 Oral insulin therapy |
| 01/15/2004 | WO2003055992A3 A method for the establishment of a pluripotent human blastocyst-derived stem cell line |
| 01/15/2004 | WO2003054228A3 Human cellular enzymes as targets against hepatitis c virus infections |
| 01/15/2004 | WO2003053401A3 Formulation and dosage form for increasing oral bioavailability of hydrophilic macromolecules |
| 01/15/2004 | WO2003053349A3 Inhibitors of hepatitis c virus |
| 01/15/2004 | WO2003051797A3 Small-molecule inhibitors of interleukin-2 |
| 01/15/2004 | WO2003051296A3 Improved skin barrier function and cohesion through enhanced stratum corneum acidification |
| 01/15/2004 | WO2003049697A3 Treatment of glioblastoma with thymosin-alpha 1 |
| 01/15/2004 | WO2003049682A3 Composition and method for treating chronic allograft rejection |
| 01/15/2004 | WO2003039487A3 Cyclo(prolyl-glycine) and methods of use to treat neural disorders |
| 01/15/2004 | WO2003039466A3 Method of treating estrogen responsive breast cancer |
| 01/15/2004 | WO2003023048A3 METHODS FOR DIAGNOSING AND TREATING DISEASES AND CONDITIONS ASSOCIATED WITH PROTEIN KINASE C$g(l) |
| 01/15/2004 | WO2003012048A3 Antigens of and antibodies to translocated molecules of microorganisms and uses thereof |
| 01/15/2004 | WO2002095032A3 Methods and compositions of human proteins and uses thereof. |
| 01/15/2004 | WO2002086093A3 Methods of using a hyaluronan receptor |
| 01/15/2004 | WO2002080888A3 Estrogen receptor-related receptor alpha (err) agonist for inducing cartilage formation |
| 01/15/2004 | WO2002078526A3 Cancer-testis antigens |
| 01/15/2004 | WO2002072607A3 Soluble heterodimeric cytokine receptor |
| 01/15/2004 | WO2002072023A3 Production of high levels of transgenic factor viii with engineered stability, and its therapeutic uses |
| 01/15/2004 | WO2002061037B1 Administration of nucleic acid sequence to female animal |
| 01/15/2004 | WO2002060935A8 A chimeric protein comprising non-toxic pseudomonas exotoxin a and type iv pilin sequences |
| 01/15/2004 | WO2002056833A3 Preparation of a therapeutic composition |
| 01/15/2004 | WO2002046364A8 Genes associated with mechanical stress, expression products therefrom, and uses thereof |
| 01/15/2004 | WO2002042777A3 Modulation of the interaction between evh1 domains |
| 01/15/2004 | US20040010814 Comprises nucleotide sequences coding kinases for developing contraceptives and controlling sex determination in animals |
| 01/15/2004 | US20040010812 Comprises nucleotide sequences coding receptor for hyaluronic acid mediated motility (RHAMM) for diagnosing, preventing, prognosing and treating tumor disorders; gene expression inhibition; antisense therapy |
| 01/15/2004 | US20040010811 Mixture comprising modulator for cancer activity; anticarcinogenic agents; tumor diagnosis; immunotherapy |
| 01/15/2004 | US20040010810 Producing xenogeneic monocolnal antibody for diagnosis and treatment of cancer, inflammation, allergies and asthma, autoimmune and cardiovascular diseases; immunotherapy |
| 01/15/2004 | US20040010306 A gradual removal of injured and diseased tissue providing a multilayer form of treatment such as regeneration or preventing proliferation of body tissue; biodegradable; stents; patches |
| 01/15/2004 | US20040010251 Methods, devices, and preparations for intervertebral disc treatment |
| 01/15/2004 | US20040010135 Comprises nucleotide sequences coding polypeptide for preventing and viral infection; viricides |
| 01/15/2004 | US20040010134 Albumin fusion proteins |
| 01/15/2004 | US20040010132 53 human secreted proteins |
| 01/15/2004 | US20040010123 Novel cocoa albumin and its use in the production of cocoa and chocolate flavor |
| 01/15/2004 | US20040010120 Novel polypeptides and nucleic acids encoding same |
| 01/15/2004 | US20040010119 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040010118 Novel proteins and nucleic acids encoding same |
| 01/15/2004 | US20040010117 Comprises streptococcal protein which inhibits hemolysis (SIC) for preventing and treating glomreulonephritis and rheumatic fever; genetic vaccines |
| 01/15/2004 | US20040010116 Comprises peptide for treating cancer, nervous system, autoimmune and arthritic disorders; high throughput assay; epitope mapping; drug design |
| 01/15/2004 | US20040010045 Therapeutic compositions comprised of pentamidine and methods of using same to treat cancer |
| 01/15/2004 | US20040010043 Treatment of cancers |
| 01/15/2004 | US20040010002 Also identifying agents that are useful for alleviating and inhibiting lymphoproliferative disorders or inhibiting metastasis of lymphatic tumors |
| 01/15/2004 | US20040010001 Methods and compositions for modulating cell proliferation and cell death |
| 01/15/2004 | US20040009984 Increasing levels of endogenous growth hormone, especially treating osterporosis, aging frailty or congestive heart failure |
| 01/15/2004 | US20040009980 Calcilytic compounds |
| 01/15/2004 | US20040009966 Interleukin converting enzyme inhibitors |
| 01/15/2004 | US20040009951 DNA deamination mediates innate immunity to (retro)viral infection |
| 01/15/2004 | US20040009950 Secreted human proteins |
| 01/15/2004 | US20040009948 Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase |
| 01/15/2004 | US20040009947 Compounds and methods for enhancing delivery of free polynucleotide |
| 01/15/2004 | US20040009946 Modulation of PTP1B expression and signal transduction by RNA interference |
| 01/15/2004 | US20040009941 Microspheres and adjuvants for DNA vaccine delivery |
| 01/15/2004 | US20040009940 Gene delivery formulations and methods for treatment of ischemic conditions |
| 01/15/2004 | US20040009939 Methods of enhancing immune induction involving MDA-7 |
| 01/15/2004 | US20040009937 Intranasal administration of an immunogenic composition of a microflora organism having an expression vector wherein said expression vector comprises a heterologous nucleic acid that encodes for an antigen. |
| 01/15/2004 | US20040009936 Vaccine and drug delivery by topical application of vectors and vector extracts |
| 01/15/2004 | US20040009935 Antisense oligonucleotides, targeted to nucleic acids encoding p21-activated kinase 2, that inhibit the expression of the kinase |
| 01/15/2004 | US20040009925 Tetrapeptide stimulating the fuctional activity of hepatocytes, pharmacological substance on its basis and the method of its application |
| 01/15/2004 | US20040009924 Anticancer products for treating cystic fibrosis |
| 01/15/2004 | US20040009922 A PKC V5 isozyme-specific peptide, or a modification, derivation, fragment, combination, or hybrid thereof |
| 01/15/2004 | US20040009921 Inhibiting the proliferation of a eukaryotic cell whose growth is stimulated by beta-catenin-mediated gene transcription by administering a non-endogenous source of RXR nuclear receptor protein, and an agonist of the protein |
| 01/15/2004 | US20040009920 Comprising angiogenesis inhibitors and RGD-containing plasma adhesion proteins in a pharmaceutical carrier. |
| 01/15/2004 | US20040009919 Protein kinase C peptides for use in withdrawal |
| 01/15/2004 | US20040009917 Method for the reduction or prevention of post-surgical adhesion formation |
| 01/15/2004 | US20040009916 Purified BMP-2 and BMP-4 proteins used in the treatment of bone and cartilage defects and in wound healing and related tissue repair. |
| 01/15/2004 | US20040009915 Polynucleotides encoding a novel intracellular chloride channel-related polypeptide |
| 01/15/2004 | US20040009913 Detecting, identifying and screening for srf signal transduction pathway elements for diagnosis |
| 01/15/2004 | US20040009912 Method for treating schizoprhenia and related phychoes, and the use of erythropoietin or erythropoietin derivatives for treating schizophrenic disorders and related pyschoes |
| 01/15/2004 | US20040009911 Hepsin substrates and prodrugs |
| 01/15/2004 | US20040009910 Compositions and methods for treating infections using analogues of indolicidin |
| 01/15/2004 | US20040009908 Treating or preventing myocardial oxidative stress by administering erythropoietin at a concentration that does not increase the hematocrit |
| 01/15/2004 | US20040009907 Nucleic acids encoding cytoplasmic, nuclear, membrane bound, and secreted polypeptides, as well as vectors, host cells, antibodies, and recombinant methods for production |
| 01/15/2004 | US20040009906 Induction of antigen specific immunologic tolerance |
| 01/15/2004 | US20040009905 Templates consist of cyclized peptides containing at least two residues in said cyclized peptide are joined by a naphthyl ring; and having bonded to it a linear peptide |
| 01/15/2004 | US20040009904 APL immunoreactive peptides, conjugates thereof and methods of treatment for aPL antibody-mediated pathologies |
| 01/15/2004 | US20040009902 CTP extended erythropoietin |
| 01/15/2004 | US20040009901 Identifying and administering an agent that enhances NADPH oxidase activity; diagnosing an autoimmune condition accompanied by NADPH oxidase deficiency |